Does Being Overweight Impact Your Regenexx-SD Knee Outcome?

knee stem cell research

Does having a few extra pounds reduce your chances of a successful outcome with the Regenexx-SD stem cell procedure for knee arthritis? For years, we have followed the same guidelines as the knee micro fracture procedure, where higher BMI (Body Mass Index) generally means worse outcomes. However, while our Regenexx-C cultured stem cell procedure data showed less robust cell growth for heavier men and women, that didn’t translate to a worse clinical outcome for heavier patients (see below). Despite this, we didn’t know how the Regenexx-SD knee procedure would fare. Would it also be agnostic toward body weight or would it follow the outcomes of many knee surgery procedures where heavier patients had less robust results? I am pleased to report this morning that our knee stem cell research on Regenexx-SD data for knee arthritis follows the same metrics as the Regenexx-C procedure in that heavier patients had no different results than lighter patients. Again, we have dissuaded many heavier patients from undergoing the same day procedure because we weren’t sure which way this data would turn out and that was the right thing to do. In addition, it’s important to note that we have no idea if the same will hold true for other stem cell procedures that use fat or bedside machines, only that our registry data is clear for our proprietary knee stem cell procedure. The upshot? if you have some extra pounds, while we may recommend dietary changes to help your cells, those extra pounds don’t seem to hurt your chances of a good outcome. Click here or the thumbnail above for the PDF.

sex bmi data

RegenexxCayman is an independently owned and operated medical services provider operating exclusively in the Cayman Islands and is not part of or affiliated with the Centeno-Schultz Clinic or any U.S. Regenexx Network provider. The Regenexx-C procedure licensed by RegenexxCayman is not approved by the U.S. FDA for use in the United States.

Learn More About Regenexx® Procedures
Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.
We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

TO TOP